Trials / Unknown
UnknownNCT04698616
Lean Body Mass and Side Effects in Patients With Lymphoma
The Relation Between Lean Body Mass and Side Effects Induced by Chemotherapy in Patients With Lymphoma: A Prospective Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 141 (estimated)
- Sponsor
- Jens Rikardt Andersen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose is to investigate the relationship between the dose of chemotherapeutic agents per kilogram of lean body mass (LBM) and the development of side effects induced by chemotherapy in patients with lymphoma. Secondarily, the maximum tolerable dose of chemotherapeutics (MTD), patients' quality of life (QOL), nutritional status and physical activity during the course of treatment are estimated.
Conditions
Timeline
- Start date
- 2020-02-09
- Primary completion
- 2021-01-31
- Completion
- 2021-03-03
- First posted
- 2021-01-07
- Last updated
- 2021-01-07
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04698616. Inclusion in this directory is not an endorsement.